Viavi Solutions faces earnings test as AI testing demand surges

Viavi Solutions is expected to report fiscal Q3 EPS of 23 cents on revenue of $393.8 million, up 54% and 38% year over year, respectively, with investors focused on whether AI infrastructure demand can sustain recent growth. Analysts keep a Strong Buy rating, but the $40.43 mean target sits about 6% below the current share price near $43, reflecting a sharp 433% rally from the 52-week low. The key watch item is fiscal Q4 guidance and whether margins can keep improving as AI-related testing demand expands.

Analysis

VIAV is behaving less like a software-style multiple story and more like a levered call option on AI capex breadth. The market is rewarding evidence that validation spend is moving up the stack from core optics into adjacent bottlenecks such as PCIe and silicon photonics, which matters because those categories tend to expand when hyperscalers transition from pilot builds to volume deployment. That creates a second-order benefit for test vendors with broad product coverage: once a customer standardizes a validation workflow, switching costs rise and revenue can compound faster than end-market growth.

The main risk is that the stock is now priced for continued operating leverage rather than just top-line growth. A strong print may not be enough if guidance suggests the AI validation cycle is still concentrated in a handful of programs, because the market will start discounting timing risk around order digestion and customer concentration over the next 1-2 quarters. The key tell is whether gross margin can keep expanding while revenue accelerates; if not, this can revert to a high-beta momentum name instead of a durable compounder.

The contrarian setup is that consensus may be underestimating how quickly the street can rotate away from VIAV if growth normalizes even modestly. With estimates already stable and the stock far above prior lows, the asymmetry is no longer in owning a beat; it’s in whether management can prove the AI mix is recurring enough to support a higher base multiple. If the company merely meets and raises by a small amount, the stock can still sell off as investors de-risk after a multi-bagger move.

Goldman’s caution on gold is relevant only as a positioning analog: crowded narratives can stay intact until one guidance reset forces a sharp unwind. VIAV fits that pattern—momentum is strong, but the next 30-60 days will likely be driven by forward commentary rather than the quarter itself. Any sign that 1.6T/PCIe demand is incremental rather than broad-based would be a warning that the upside is more cyclical than structural.

Key Decisions for Investors

• If long VIAV, hedge into earnings with a 1-2 month put spread or a collars structure; the setup favors upside on a beat, but guidance risk can dominate if the AI backlog looks narrow.
• For traders looking to express the AI validation theme, pair long VIAV / short a slower-growing network-testing peer over the next 1-3 months; the relative setup is better than a naked long because the market is paying for execution, not just category exposure.
• If the print confirms sustained gross margin expansion, add on the first post-earnings pullback rather than chasing the open; the better entry is after the initial volatility when guidance quality is digested.
• If management frames AI demand as project-driven rather than recurring, fade rallies with a tight stop; the stock’s prior run leaves little margin for a guidance miss or softer Q4 implied growth.